Creative Medical Technology
CELZ
8 hedge funds and large institutions have $441K invested in Creative Medical Technology in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$168K |
| 2 |
Jane Street
New York
|
+$130K |
| 3 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$49.8K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$47.6K |
| 5 |
LCS
Levin Capital Strategies
New York
|
+$21K |
Top Sellers
CELZ Hedge Fund Activity: Q4 2021 in Review
8 of the 6,517 institutional investors tracked by Wall St. Rank reported a position in Creative Medical Technology (CELZ) for Q4 2021, worth a combined $441K.
Buyers outnumbered sellers: 8 funds opened new CELZ positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $168K.
- 8 institutional investors held Creative Medical Technology (CELZ) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $441K of Creative Medical Technology stock for Q4 2021.
- 8 funds opened new Creative Medical Technology positions in Q4 2021 and 0 closed out, a net change of +8 holders.
- The largest Creative Medical Technology buyer in Q4 2021 was Hudson Bay Capital Management, an estimated $168K added.
Based on aggregated 13F filings for Q4 2021.